Bistoni F, Pitzurra M, Marconi P
Boll Ist Sieroter Milan. 1983;62(6):575-9.
The passive haemagglutination assay is at present the most common method available for evaluating tetanus antibody levels. We recently developed a modification of the technique of HA by Mai and Rosin using turkey red blood cells (TRBC-HA) instead of sheep red blood cells (SRBC-HA). TRBC-HA assay seems to offer the advantages of being more sensitive and easier to perform than the SRBC-HA method. More important, with the TRBC-HA assay, we found that the HA values greater than 0.5 H.U./ml always correspond to NT values greater than 0.01 IU/ml. Therefore this value (0.5 H.U./ml) was chosen as a discriminating level between protected and non protected persons. On this rationale base we have tested sera from injured persons in order to individualize a single prophylactic treatment under a rationale guideline against the alternative of a blind intervention under anamnestic basis. Among 437 persons tested 248 did not remember if they had been vaccinated or not. According to the anamnestic basis all these persons should require injection of human antitetanus Ig plus a basic course of vaccination. On the contrary antitetanus antibody levels monitored by TRBC-HA assay indicate that 132 were protected and did not require any treatment; 79 were partially protected and required a boosting of tetanus toxoid and only 37 were not protected and needed human antitetanus IgG plus a complete course of vaccination. These results underline the necessity of monitoring a single person for antitetanus antibodies in order to prevent both under or over evaluation of their tetanus immune status.
目前,被动血凝试验是评估破伤风抗体水平最常用的方法。我们最近对Mai和Rosin的血凝技术进行了改进,使用火鸡红细胞(TRBC-HA)代替绵羊红细胞(SRBC-HA)。TRBC-HA试验似乎比SRBC-HA方法更敏感且更易于操作。更重要的是,通过TRBC-HA试验,我们发现血凝值大于0.5 H.U./ml总是对应于中和效价大于0.01 IU/ml。因此,选择该值(0.5 H.U./ml)作为区分受保护者和未受保护者的水平。基于这一理论基础,我们检测了受伤者的血清,以便在合理的指导方针下确定单一的预防性治疗方案,而不是在既往史基础上进行盲目干预。在437名接受检测的人中,有248人不记得自己是否接种过疫苗。根据既往史,所有这些人都应该注射人抗破伤风免疫球蛋白并接种基础疫苗疗程。相反,通过TRBC-HA试验监测的抗破伤风抗体水平表明,132人受到保护,无需任何治疗;79人部分受保护,需要加强破伤风类毒素;只有37人未受保护,需要人抗破伤风免疫球蛋白并接种完整的疫苗疗程。这些结果强调了监测个体抗破伤风抗体的必要性,以防止对其破伤风免疫状态的评估不足或过度。